This is a success message.
This is an error message.
This is also an error message.
Company news

High-Throughput Label-free Cell Interaction Studies

At the ASCB | EMBO 2017 meeting, we introduced z-Movi®, a new platform for cell interaction studies.

This new method enables direct and label-free screening and sorting of thousands of cells based on their interaction with cell or protein targets. z-Movi® is a breakthrough technology for research and development of personalized therapies, including immunotherapy. It is the first platform able to directly measure the strength of interaction, or avidity, between cells with specific targets and sort cells of interest, in a high-throughput and label-free manner.

Want to learn more about z-Movi®? Contact us for more information, a demo or a quote.

Latest company news

Learn as much as you can by reading up on our application notes or marathoning our webinars.

View all
LUMICKS CEO Hugo de Wit Featured in SoftBank Vision Fund Interview
LUMICKS CEO Hugo de Wit Featured in SoftBank Vision Fund Interview
Company news
July 14, 2025
01-01-20

Putting our unused lab equipment to better use
Putting our unused lab equipment to better use
Company news
May 26, 2023
01-01-20

Dynamic Single-molecule workshop at Westlake University
Dynamic Single-molecule workshop at Westlake University
Company news
September 6, 2021
01-01-20

LUMICKS technologies installed all around the world
LUMICKS technologies installed all around the world
Company news
February 23, 2021
01-01-20